Cardio Diagnostics Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDIO research report →
Price Chart
About the company
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease.
- CEO
- Meeshanthini V. Dogan
- IPO
- 2022
- Employees
- 15
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on CDIO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.92M
- P/E
- -0.68
- PEG
- -0.06
- P/S
- 409.62
- P/B
- 0.80
- EV/EBITDA
- -0.11
- Div Yield
- 0.00%
- Gross Margin
- -555.03%
- Op Margin
- -44690.68%
- Net Margin
- -44771.83%
- ROE
- -82.27%
- ROIC
- -82.84%
Latest fiscal year · YoY change
- Revenue
- $14.82K-57.5%
- Gross Profit
- $14.82K-57.5%
- Op Income
- $-6,484,078
- Net Income
- $-6,498,167+22.5%
- EPS
- $-3.71+60.1%
- OCF Growth
- -14.7%
- FCF Growth
- -9.6%
- 52W High
- $7.91
- 52W Low
- $0.97
- 50D MA
- $1.89
- 200D MA
- $2.17
- Beta
- 2.24
- RSI (14)
- 55
- Avg Volume
- 56.34K
No earnings-call transcripts are available for CDIO yet.
- Free Float
- 95.8%
- Shares Outstanding
- 2.96M
- Float Shares
- 2.83M
of shares held by institutions
16 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Renaissance Technologies LLC | 49.20K | ▲ 33.85K |
| Blackrock, Inc. | 34.71K | 0 |
| Geode Capital Management, LLC | 26.23K | ▼ 5.94K |
| Vanguard Group Inc | 24.12K | 0 |
| Vanguard Capital Management LLC | 20.16K | 0 |
| Citadel Advisors LLC | 19.07K | ▲ 19.07K |
| Xtx Topco Ltd | 16.09K | ▲ 16.09K |
| Jane Street Group, LLC | 11.93K | ▼ 69.35K |
| State Street Corp | 10.10K | ▲ 10.10K |
| Vanguard Fiduciary Trust Co | 2.82K | ▼ 1.15K |
| Tower Research Capital LLC (Trc) | 1.81K | ▼ 383 |
| Ubs Group AG | 656 | ▼ 9.26K |
Held by 6 ETFs
Biggest fund positions in CDIO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 30, 26 | Betts Wendy J | other | 3,286 |
| Sep 30, 26 | Fung Peter K | other | 3,286 |
| Sep 30, 26 | Intrater James | other | 3,286 |
| Sep 30, 26 | Burton Paul Frederick | other | 3,286 |
| Jun 30, 26 | Fung Peter K | other | 2,854 |
| Jun 30, 26 | Betts Wendy J | other | 2,854 |
| Jun 30, 26 | Intrater James | other | 2,854 |
| Jun 30, 26 | Burton Paul Frederick | other | 2,854 |
| Mar 31, 26 | Fung Peter K | other | 3,205 |
| Mar 31, 26 | Betts Wendy J | other | 3,205 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CDIO coverage
Recent articles, reports, and earnings notes.
No research on CDIO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CDIO report →Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Shares Shorted: Short Interest Down 77.7% in September
defenseworld.net · Sep 28
Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com · Sep 18
Cardio Diagnostics (NASDAQ:CDIO) & Sutro Biopharma (NASDAQ:STRO) Head-To-Head Analysis
defenseworld.net · Aug 29
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
gurufocus.com · Aug 26
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
businesswire.com · Aug 26
Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript
seekingalpha.com · Aug 20
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
businesswire.com · Aug 18
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
businesswire.com · Aug 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.